Framing international trade and chronic disease

Area of Science:

• Global Health
• Health Economics
• International Trade Policy

Background:

• Emerging evidence links global trade to increased chronic disease rates in low and middle-income countries (LMICs).
• This rise is partly due to the spread of unhealthy lifestyles and harmful products, complicating health challenges in LMICs.
• The issue is increasingly recognized in global policy, as seen in the UN Summit on Noncommunicable Diseases.

Purpose of the Study:

• To develop a framework illustrating the connection between global trade and chronic diseases.
• To apply this framework to key risk factors: unhealthy diets, alcohol, and tobacco.
• To inform health and trade policymakers on the health impacts of trade agreements.

Main Methods:

• Developed a generic framework detailing determinants and pathways linking global trade to chronic disease.
• Applied the framework to analyze 'product pathways' for unhealthy diets, alcohol, and tobacco.
• Synthesized findings to guide policy engagement and research refinement.

Main Results:

• Identified specific 'product pathways' demonstrating how trade influences chronic disease risk factors.
• Highlighted the need for health policy-makers to engage with trade policy-makers on treaty negotiations.
• Emphasized the role of trade policies in the global spread of noncommunicable disease risk factors.

Conclusions:

• A more concerted approach is needed to regulate trade-related chronic disease risk factors.
• Increased engagement between health and trade policy sectors is crucial within and between nations.
• Future trade treaties must explicitly consider and avoid increasing noncommunicable disease risks.